Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risedronate With High-dose Vitamin D Resolves Hyperparathyroidism and Hypovitaminosis D But Not Osteoporosis in Mexican Postmenopausal Patients

NCT05346419 is registered in ClinicalTrials.gov with Hospital Regional 1o de Octubre as lead sponsor.

NCT NCT05346419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05346419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risedronate With High-dose Vitamin D Resolves Hyperparathyroidism and Hypovitaminosis D But Not Osteoporosis in Mexican Postmenopausal Patients
Lead sponsor
Hospital Regional 1o de Octubre
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2021
Completion date
February 26, 2022
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperparathyroidism, hypovitaminosis d, postmenopausal osteoporosis